Bio-engineered organs for transplantation may ultimately provide a personalized solution for endstage organ failure, without the risk of rejection. Building upon the process of whole organ perfusion decellularization, we aimed to develop novel, translational methods for the recellularization and regeneration of transplantable lung constructs.
We first isolated a proliferative KRT5 + TP63 + basal epithelial stem cell population from human lung tissue and demonstrated expansion capacity in conventional 2D culture. We then repopulated acellular rat scaffolds in ex vivo whole organ culture and observed continued cell proliferation, in combination with primary pulmonary endothelial cells. To show clinical scalability, and to test the regenerative capacity of the basal cell population in a human context, we then recellularized and cultured isolated human lung scaffolds under biomimetic conditions. Analysis of the regenerated tissue constructs confirmed cell viability and sustained metabolic activity over 7 days of culture. Tissue analysis revealed extensive recellularization with organized tissue architecture and morphology, and preserved basal epithelial cell phenotype. The recellularized lung constructs displayed dynamic compliance and rudimentary gas exchange capacity. Our results underline the regenerative potential of patient-derived human airway stem cells in lung tissue engineering. We anticipate these advances to have clinically relevant implications for whole lung bioengineering and ex vivo organ repair.
INTRODUCTION
Solid organ bioengineering based on native extracellular matrix scaffolds has fuelled recent enthusiasm for regenerative medicine approaches to treat end organ failure (1) . The main approach involves combining regenerative cell populations with corresponding biological matrices to form living, functional grafts. To this end, native solid organ extracellular matrix (ECM) scaffolds can be readily generated by perfusion decellularization with specific detergents, rendering a biocompatible framework as a foundation for regeneration (2) (3) (4) (5) (6) (7) .
Clinically relevant organ recellularization presents significant challenges, both in terms of identifying an ideal cell source and in the establishment of functional biomimetic organ culture systems to support organ maturation prior to transplantation (8) . An optimal cell source would be easily obtained and expanded in vitro, while maintaining contact inhibition and cell cycle control. Directed differentiation of induced pluripotent stem cells through key developmental stages presents a promising option for obtaining lung-specified cell populations (9) (10) (11) , but the length of in vitro culture and limited cell number and purity restricts their current utility for large-scale organ engineering. While largely quiescent, adult lung tissue has a remarkable capacity for regeneration, owing to a number of facultative stem/progenitor cell populations that become activated in response to tissue damage (12) . Airway basal cells, identified by the transcription factor TP63 and expression of cytokeratin 5 (KRT5), function as multipotent stem cells of the proximal airway epithelium, and are critical for maintaining airway homeostasis during physiological cell turnover and regeneration (13, 14) . This essential cell population comprises 30% of the cells in human airway epithelium (15) , and early studies of airway regeneration have demonstrated the ability for isolated basal cells to recapitulate a fully differentiated airway epithelium when seeded onto denuded mouse tracheas (16) . In response to injury, basal epithelial stem cells can rapidly proliferate and give rise to both ciliated and club cell progeny, confirming their important function in tissue homeostasis and injury repair (17) . Basal cells can be isolated (18, 19) and propagated in culture (20) , which makes them a useful candidate population for tissue and organ engineering applications. We demonstrate that this population can be readily derived from human cadaveric lung tissue following clinical organ donation and cold ischemia, and expanded in vitro. This isolated primary stem cell population also provides an important tool for studying basic biology and tissue regeneration (13) , particularly given their role in lung repair and capacity for multi-lineage differentiation (21, 22) . Following injury, basal airways stem cells have been reported to undergo rapid proliferation, migration, and a surprising differentiation toward distal pneumocyte lineages, in order to reconstitute the damaged alveolar-capillary network (23) . When delivered to rodent lungs following injury, TP63 + KRT5 + cells have been shown to differentiate to type I and type II pneumocytes, in addition to bronchiolar secretory cells (24) . Lung repair and remodelling after influenza or bleomycin injury may also involve a specialized subset of KRT5 + cells (25, 26) . Although this phenomenon has yet to be investigated in the context of epithelial tissue engineering, these studies highlight the evolving understanding of traditional cell identity, hierarchy, and regenerative ability.
In the present study, we aimed to exploit the capacity for lung basal stem cells to respond to injury and to re-establish epithelial integrity and functional organization (13, 27) , by investigating the utility of human donor tissue-derived cells in the context of whole organ engineering. We propose that the architectural and biological niches retained within the native extracellular matrix may provide a valid template to guide cell engraftment and investigate mechanisms of lung tissue repair (28, 29) , and in combination with extended biomimetic culture, provide an important platform for the regeneration of human lung constructs.
METHODS

Study Approval
Human donor lungs otherwise unsuitable for transplantation were obtained from the New England Organ Bank (see Supplementary Table 1) , following informed consent. All experiments were approved by the Massachusetts General Hospital Internal Review Board (#2011P002433) and Animal Utilization Protocol (#2014N000261).
Cell isolation and Expansion
Donor lung peripheral tissue was gently homogenized and digested in 0.1mg/ml DNAse (Sigma) and 1.4mg/ml Pronase (Roche, 11459643001) for 24 hours/4°C (30) . Digested tissue was plated onto uncoated culture flasks for 30 minutes/37°C, then non-adherent cells transferred to culture on human Collagen-IV (Sigma-Aldrich C7521)-coated flasks and maintained in Small Airway Growth Media (SAGM, Lonza, CC-3118). Primary endothelial cells were isolated from the large vessels of donor lungs using the same digestion protocol. The endothelial population was sorted for CD31 + purity by flow cytometry, and maintained and expanded on Gelatin-coated flasks in EGM2 (Lonza, CC-3162) until utilized for lung scaffold recellularization (See Supplemental Figure 1 ). For in vitro co-culture, endothelial cells were plated onto a 0.4μm transwell insert (Corning, 07200161) placed above the epithelial cell culture, and maintained in SAGM, with or without the addition of 40ng/ml VEGF (Peprotech), for 7 days.
Air-Liquid Interface Culture
Primary epithelial cells at passage 3 were plated onto 0.4μm Transwell inserts coated with collagen IV and maintained in submerged culture with SAGM for 5 days. Media was replaced with PneumaCult™-ALI medium (Stemcell Technologies, 05001) in the basal chamber only, and maintained for 21 days at Air-Liquid interface, with alternate day media changes.
3-Dimentional Sphere Assay
Primary basal epithelial cells at passage 3 were filtered through a 40μm mesh to remove any cell clumps then transferred onto a 0.4μm Transwell insert (5000 cells/90uL of 50:50 matrigel-to-SAGM substrate), following a previously published protocol (31) . Single cell suspension was confirmed by light microscopy (40×). Cultures were maintained with SAGM in the basal chamber only for 7 days.
Lung Decellularization
Rat and human donor lungs were decellularized as previously described (2, 6) . Briefly, cadaveric rat lungs were explanted from male Sprague-Dawley rats (250-300 g, Charles River Laboratories) and decellularized by perfusion of 0.1% SDS solution through the pulmonary artery at 40mmHg, followed by washing. Human lung decellularization was performed by perfusion of 0.5% SDS solution through the pulmonary artery at a constant pressure between 30 mmHg and 60 mmHg.
Rat Lung Recellularization and Culture
Where indicated, primary pulmonary endothelial cells (CD31 + , 10×10 6 total cells) were first delivered to the pulmonary artery in 100ml of media at a constant pressure of 30mmHg. After 90 minutes of static incubation (37°C), 20×10 6 cells primary lung epithelial cells (passage 4) were delivered to the scaffold airways in 20ml of media by gravity. Constant media perfusion of SAGM with 40ng/ml Vascular Endothelial Growth Factor (VEGF) through the pulmonary artery was maintained at 4ml/min and changed daily. Continuous positive airway pressure (CPAP) of 20cmH 2 O with room air (21% FiO 2 ) was initiated on day 2 of culture and maintained for 2-hours/day. Recellularized lungs (n=3 individual lungs per group) were maintained in culture for 7 days. From each lung n=3 representative tissue samples from the upper, middle, and lower lung were saved for both histologic and mRNA analysis.
Human Lung Recellularization and Biomimetic Culture
A total of 160-240×10 6 primary pulmonary endothelial cells were first delivered to the vasculature via the pulmonary artery and vein by pump, at a constant pressure of 50mmHg (32) . After 90 minutes, a total of 220-280×10 6 epithelial cells (passage 4) were delivered to the main airway in solution (500ml media) by pump at 50ml/min. For each recellularization experiment, the cells were isolated from a unique donor. A total of n=3 independent lobes were recellularized, in separate experiments. For recellularization, the cells and the scaffold were not donor matched.
Constant perfusion of SAGM with 40ng/ml Vascular Endothelial Growth Factor (VEGF) was maintained for 7 (n=2) or 10 (n=1) days at 20-40ml/min. Perfusion pressure was continuously monitored and maintained within physiologic range (mean = 21.39 ± 4.53mmHg, see Figure 5C ). Negative pressure ventilation was generated via chamber pressure oscillations to achieve a breath rate of 6 breath-cycles/minute with a positive end expiratory pressure (PEEP) of 8mmHg. Ventilation was initiated on day 3 of culture and maintained for 2-hours/day. Media samples from the pulmonary artery, pulmonary vein, and chamber were tested by iSTAT cartridge (CG4+/CG8+, Abbott) daily.
Positive pressure ventilation was performed on the final day of culture. Volume-controlled ventilation was applied using a Drager Evita-4 ventilator, with a tidal volume of 150-200mL, a PEEP of 5mmHg, and a respiratory rate of 12 breaths/min. Samples were analyzed after 10 minutes of ventilation with a FiO 2 of 21% and again after 10 minutes with and FiO 2 of 100%, using a GC3+ iSTAT cartridge. On the final day of culture, a 0.05mM Resazurin solution (500ml) was circulated for 90 minutes at a constant flow of 30ml/min. Resazurin reduction was measured by fluorescence in culture media (excitation 544nm, emission 590nm), and compared to a standard curve of known cell numbers in vitro (50:50 mixture of epithelial-to-endothelial cells, cultured for 90 minutes in Resazurin-containing media, n=3 replicates) to calculate an estimate of total cell number in recellularized lungs. Tissue samples were fixed in 5% formalin, or saved in RNAlater (Qiagen) for subsequent analysis. From each recellularized lobe (n=3), a total of n=4 representative tissue samples from the upper, middle, and lower lung were saved for both histologic and mRNA analysis.
Quantitative PCR
mRNA was isolated (Qiagen RNeasy Plus Kit) and transcribed to cDNA (Invitrogen SuperScript III). Gene expression was analyzed using Taqman probes and the OneStep Plus system (Applied Biosystems). Each biological sample was analyzed in experimental replicate (n=2 repeated wells of the qPCR reaction) with the Ct value of each replicate averaged and handed as n=1 unique biologic sample. Expression for each sample was normalized to β-Actin (ACTA1) gene expression (ΔCt) and relative to cadaveric peripheral lung tissue control samples (ΔΔCt), with fold change calculated by 2 −ΔΔCt (33).
Immunostaining
Following de-paraffinization and rehydration, 5μm tissue section were permeablized with 0.1% triton-x for intracellular antigens, when appropriate. Cells in culture were fixed with ice-cold methanol prior to staining. All samples were blocked with 1% donkey serum for 1hr. Primary Antibodies (all 1:100): TP63 (Santa Cruz, sc-25268), KRT5 (Abcam, ab24647), E-cadherin (CDH1, BD, 610181), Surfactant Protein-B (Millipore, AB3430), proSurfactant Protein-C (Abcam, ab3786), Aquaporin-5 (Abcam, ab92320), Acetylated α-Tubulin (TUBA1B, Abcam, ab24610), α2β1 integrin (Abcam, ab24697), α3β1 integrin (Abcam, ab24696), KI67 (Millipore, AB9260) and CD31 (Dako, M082301-2). Secondary antibodies all (1:400): Alexafluor Donkey anti-Mouse, Rabbit, or Goat, conjugated to 488 or 594 (Life Technologies). Samples were stained with 4′,6-diamidino-2-phenylindole (DAPI) to visualize the nucleus and imaged using a Nikon Ti-Eclipse microscope.
Trypan blue (0.4%) staining following ROCK inhibitor Y27632 (10uM) treatment (Supplemental figure 2B) was visualized by bright-field image on the Nikon Ti-Eclipse microscope. β-galactosidase staining following ROCK inhibitor Y27632 (10uM) treatment (Supplemental figure 2C ) was performed following the manufacturer's instructions (Cell Signaling Technology #9860), and visualized by bright-field image on the Nikon Ti-Eclipse microscope.
Statistical Analysis
For all experiments, the n value stated represent an independent biological sample. Data was analyzed by Mann Whitney U-test or Kruskall-Wallis with a Dunn's multiple comparison posttest, as appropriate, using GraphPad Software. All statistical significance is reported accordingly. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
RESULTS
We first isolated and characterized a highly proliferative cell population from human cadaveric lung tissue. Robust expansion of a KRT5 + TP63 + basal epithelial stem cell population was reproducible over serial passages in culture, with increased expression of ECadherin and loss of pro-SP-B and αTubulin positive cells. (Figure 1A-B) . The proliferative capacity of the isolated cell population was maintained through 3 passages (KI67 + cells by staining, 63.4 ± 8.08%, n=3 images quantified per passage), and began to decline by passage 4 ( Figure 1C ). Phenotypic stability was examined by flow cytometric analysis of passage 1 and passage 4 cells, confirming the expansion of the KRT5 + TP63 + basal stem cell lineage (n=3 unique donor-derived cell lines analyzed. Figure 1D ). Gene expression was longitudinally profiled (n=3 donor-derived cell lines analyzed in biologic triplicate at each time point. Figure 1E) , additionally confirming the enrichment of the basal airway stem cell population, with a parallel loss of type 1 (HOPX1, AQP5) and type 2 (SFTPB/C) pneumocytes, and Club (SCGB1A1 + ) secretory cells. Throughout the culture period, no increase in expression of mesenchymal genes such as vimentin (VIM) or smooth muscle actin (ACTA2) was found, nor was an increase in the expression of epithelial-tomesenchymal transition associated transcription factors ZEB1 and SNAIL detected. Maximal cell proliferation at passage 3 was confirmed by quantification of KI67 gene expression. In our hands, use of ROCK inhibitor Y-27632 (34) during cell isolation and passage did not enhance the basal cell population, or alter proliferation (KI67, PCNA) or senescence (senescence-associated cyclin-dependent kinase inhibitor 2A, CDKN2A) (35) (Supplemental Figure 2) and was therefore not used for in vitro expansion. Culture of the isolated basal epithelial stem cells at air-liquid interface demonstrated their capacity for ciliogenesis at day 21 (Supplemental Figure 3A-B) . Additionally, culture of single-cell suspensions in matrigel revealed clonal generation of epithelial spheres with preservation of the KRT5 + TP63 + phenotype on day 7 (Supplemental Figure 3C-D) .
To investigate the regenerative capacity of this epithelial stem cell population in whole lung engineering, they were first used to recellularize rat lung scaffolds (Figure 2A) . The airways were repopulated with human donor-derived cells and maintained in ex vivo biomimetic culture for 7 days ( Figure 2B , Scaffold + Epithelium + , n=3 lungs). In parallel experiments, scaffolds airways were recellularized in combination with primary pulmonary endothelial cells to the vasculature (Scaffold + Epithelium + Endothelium + , n=3 lungs). Constant media perfusion through the vascular network was maintained throughout culture. Airway recruitment was performed daily and continuous positive airway pressure (CPAP) was delivered for 2 hours per day to reduce atelectasis, improve oxygenation, and enhance biomimetic stimulation during regeneration (36) (Figure 2A) . Analysis of the regenerated lung tissue confirmed a maintenance of the TP63 + KRT5 + basal epithelial stem cell lineage on day 4 and day 7 of scaffold culture. A significant increase in adherens junctions ECadherin (CDH1) was found in lungs recellularized with both epithelium and endothelium. Expression of the ciliated cell marker FOXJ1 was significantly increased in all recellularized lung after biomimetic culture. Continued proliferation, as measured by KI67 expression, was noted in all recellularized lungs, with a significance increase found in lung tissue recellularized with both pulmonary endothelial cells and basal epithelial stem cells. No increase in the activation of cellular senescence (CDKN2A) was found following lung recellularization and culture. All recellularized lung tissue was compared to cells maintained in 2D culture at the same passage for reference (n=3 independent cell lines at passage 4). We also found that co-culture of the basal epithelial stem cell population with pulmonary endothelial cells significantly increased epithelial proliferation in vitro (Supplemental Figure   4 ) which supports the effect observed in whole lung culture. Analysis by immunofluorescent staining further revealed extensive recellularization of both distal alveolar lung tissue ( Figure  2Ci -iii) and larger airways ( Figure 2C iv-v) . Reformation of native tissue morphology and architecture was observed, including both airway epithelium (TP63 + KRT5 + , CDH1 + ) and vessels (CD31 + ). Representative whole section scans identifying KRT5 + cells and CD31 + cell distribution in recellularized rat lung scaffolds on Day 7 of culture are presented in Supplementary Figure 5 .
To move towards a more clinically relevant matrix and scale, we adapted our human lung bioreactor system to enable large-scale whole organ culture and the recellularization of isolated human lung scaffolds (37) ( Figure 3A , used for n=3 independent lung recellularization experiments). We delivered the expanded basal stem cell population via the airways (220-280×10 6 cells), and primary human pulmonary endothelial cells (160-240×10 6 cells, CD31 + ) via the native artery and vein vasculature ( Figure 3B ). The bioreactor maintained a physiologic perfusion range (mean = 21.39 ± 4.53mmHg) in the ex vivo regenerating organ (n=3 experiments, Figure 3C ), while cell survival and metabolic activity were monitored in a non-invasive manner throughout the culture. Glucose consumption and lactate production in the perfusate was measured every 48 hours as a non-invasive indicator of cell growth (38) , which gradually increased over the culture period (repeated measures, n=2 independent recellularization experiments, Figure 3D -E). Negative pressure ventilation of the lung construct was achieved at 6 breaths/minute by oscillating between set chamber pressure targets, in order to facilitate airway recruitment and oxygenation during culture ( Figure 3F ). This resulted in a median peak trans-mural pressure of 15.88mmHg (14.42-21.73mmHg, n=2447 breaths), and a median tidal volume of 138.08 ml/breath (78.08-183.32 ml, n=2447 breaths) ( Figure 3G-I) . Positive pressure ventilation was performed as an end-point test of potential organ function ( Figure 3J ) and oxygenation transfer to the perfusate media was measured following ventilation at FiO 2 of 21% and 100% for 10 minutes. A resulting pO 2 of 72mmHg (PaO 2 /FiO 2 =343mmHg) was measured, which increased to 412mmHg (PaO 2 /FiO 2 =412mmHg), with a corresponding pCO 2 of 17.5mmHg and 24.9mmHg, respectively ( Figure 3K ). This suggests that the regenerated human lung construct can support rudimentary organ function and gas transfer following recellularization and culture.
Tissue recellularization and cell viability was visually assessed following metabolism of Resazurin-containing perfusate, noting the metabolism to a pink colour by viable cells ( Figure 4A ). Extent of coverage and cell morphology was investigated by histologic staining across multiple areas of each lobe ( Figure 4B ). Broad cell distribution throughout the repopulated scaffold, from the upper airways to the distal lung region with cell alignment in accordance with the preserved matrix architecture was found. The ability of reintroduced cells to continue expansion within the matrix was confirmed. Based on Resazurin reduction assay (39) , the total cell number contained within each scaffold at the end of culture was calculated ( Figure 4C ). An average of 9.0×10 8 cells was calculated (HL1 = 7.20×10 8 , HL2 = 1.07×10 9 , HL3 = 9.07×10 8 ), representing an continued increased compared to total cells seeded on Day 0. By staining, a robust fraction of epithelial cells remained proliferative (61.7% ± 10.4 KI67 + ) at the end of organ culture (n=3 representative areas were analyzed per lung, with 4 images quantified per area. Figure 4D -E). A preserved KRT5 + TP63 + basal stem cell phenotype was observed throughout the regenerated lung tissue (Figure 4Fi) , with a very minor contribution of non-adherent proSPB + cells identified (Figure 4Fii ). Heterogeneous endothelial cell (CD31 + ) coverage was observed throughout the vascular compartment, which corresponded with the expected distribution based on the initial cell number seeded. Rudimentary gas exchange units could be identified, represented by single layer endothelial and epithelial cells lining the alveolar-capillary interface (Figure 4Gi ) and repopulated vascular conduits were found (indicated by white arrow, Figure 4Gii ). The regenerated tissue was further analyzed for gene expression, confirming the maintenance of the basal stem cell population with TP63 expression greater than 25-fold higher than normal cadaveric lung tissue, (n=4 independent tissue pieces analyzed per lung, with expression level of cells in vitro presented for reference. Figure 4H) . A significant increase in FOXJ1 and KI67 expression was also found following human lung recellularization and biomimetic culture, along with a significant decrease in the cellular senescence marker CDKN2A.
Together, this data demonstrates the capacity for the clinically relevant human donor tissuederived cell populations to recellularize native matrix scaffolds and serve as an important tool for tissue engineering of lung constructs for transplantation.
DISCUSSION
We have isolated a highly proliferative basal stem cell population from an easily accessible tissue source and demonstrated rapid expansion in vitro. This cell population, identified by KRT5 + TP63 + expression, has been studied in many animal models of lung repair (40) (41) (42) and in human disease (43) .
Within the KRT5 + TP63 + population, additional distinct subpopulations of basal stem cells may exist, each with a unique role in tissue homeostasis and repair. This includes the recently reported lineage-negative epithelial progenitor (LNEP) cells within normal distal lung, which can specifically proliferate following injury (25) . It is unclear whether these rare cellular subsets can act in isolation, or if they require combined signalling and action of other cells in the injured tissue milieu. Mathematical models support a heterogeneous basal stem cell population, proposing approximately equal numbers of multipotent stem cells and committed precursors (44) . The role of injury, including source, intensity, and duration, is also an important determinant of cell activation and fate, both in vivo and in tissue engineering aims.
Following lung injury, the re-establishment of an intact epithelium is critical to quickly restore barrier function and tissue homeostasis (45) . In our model of lung repair, we propose the decellularized lung scaffold serves as the provisional matrix for epithelial cell migration, recapitulating the processes activated in vivo to cover and repair denuded airway and gas exchange surfaces (46) . The physiologic role of basal cells, to help anchor epithelial cells to the matrix and protect the underlying stroma, is aided by their expression of abundant cytoskeletal, junctional and adhesive proteins, which supports their demonstrated utility in re-epithelialization of native lung ECM (47) . For clinical utility of this methodology in autologous tissue transplantation, the source of isolated cell population must be considered. For indications with an underlying genetic cause, such as Cystic Fibrosis, it may be possible to correct the mutation in the isolated cell population prior to recellularization of the scaffold. Smoking-associated lung diseases, such as COPD, pose an unique challenge. The basal cell population isolated from COPD patients has been reported to display an altered gene expression profile and diminished capacity for regeneration (48) . While the regenerative capacity is reduced in basal cells from smokers (43), it is not a completely lost, suggesting that a regenerative subpopulation remains. It is not yet known how these COPDassociated changes would affect re-epithelialization of healthy lung scaffolds, and if specific subpopulations could be identified that specifically retain a regenerative potential. An important area of future research would include investigation of this question and development of techniques to overcome any regenerative failure. In order to reduce the amount of starting donor tissue required, additional experimental factors including longer ex vivo culture time and optimized microenvironment (biomechanics, growth factors) may be developed to enhance the recellularization process. In addition to cell origin, the source of biologic scaffold may also play an important role in regeneration capacity, both in terms of cell distribution and survival in the construct (49) .
Rodent models of airway injury have established a timeline of epithelial repair. After epithelial injury, cell spreading and migration occurs as the primary repair mechanisms in the first 12-24 hours, with proliferation beginning after 24 hours and continuing for several weeks (50) . This timeline aligns with our model of lung repair in ex vivo culture and regeneration. We have also found that proliferation of the epithelial population is enhanced by co-culture with pulmonary endothelial cells. We believe that the capacity for cellular crosstalk is an important element of whole organ regeneration, both in our model and in vivo. The influence of other cell types may have a unique effect on epithelial repair and differentiation in the context of the proximal or distal lung niche.
Following proliferation and coverage, the next step in the repair mechanism would be reestablishment of a pseudostratified epithelium, which can take several weeks to generate (51) . Our model of culture on human and rat lung scaffolds demonstrated the initial upregulation of FOXJ1 gene expression. Extended bioreactor culture may be required to fully mature the reconstituted airway epithelium, as in vitro air-liquid interface (ALI) models require 3-4 weeks to recapitulate the mature airway biology (52) . Following recellularization and ex vivo culture, we did not identify significant pneumocyte lineages incorporated within our reconstituted epithelium. Longer regeneration time, combined with modulation of key signaling pathways will likely be required to induce any potential pneumocyte differentiation from the delivered airway stem cell population, with animal models demonstrating distal lung regeneration required 50-90 days in vivo (24, 25) . Further optimization of cell delivery and biomimetic culture procedures are also required areas of future investigation to enhance regeneration.
Organ regeneration based on decellularized scaffolds is a unique model to study injury and test cell potential, as it provides a tool to investigate the essential elements of epithelial cell differentiation and repair. Given the isolated environment, coupled with the biomimetic stimulus provided by the ex vivo culture of the regenerating organ, it is possible to directly assess the specific response and capacity of individual cell populations during tissue repair. In the present study, by employing a systematic building-blocks approach, we make a critical step forward by demonstrating that a primary isolated airway stem cell population can accomplish extensive tissue regeneration on an acellular lung scaffold, and can be directed toward both proximal and distal epithelial lineages. Future advances will benefit from combined developments in bioengineering and cell biology to further mature the regenerating lung and translate this technology toward a fully reconstituted, therapeutically relevant, transplantable lung.
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